RARγ-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen

Xiang ZhangDepartment of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, PR China; ;Institute of Hematology, Zhejiang University, Hangzhou, PR China; ;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, PR China

Fenglin LiDepartment of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, PR China; ;Institute of Hematology, Zhejiang University, Hangzhou, PR China; ;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, PR China

Jinghan WangDepartment of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, PR China; ;Institute of Hematology, Zhejiang University, Hangzhou, PR China; ;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, PR China

Shanshan SuoDepartment of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, PR China; ;Institute of Hematology, Zhejiang University, Hangzhou, PR China; ;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, PR China

Qing LingDepartment of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, PR China; ;Institute of Hematology, Zhejiang University, Hangzhou, PR China; ;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, PR China

Wenjuan YuDepartment of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, PR China; ;Institute of Hematology, Zhejiang University, Hangzhou, PR China; ;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, PR ChinaCorrespondence[email protected]

Jie JinDepartment of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, PR China; ;Institute of Hematology, Zhejiang University, Hangzhou, PR China; ;Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Zhejiang, PR ChinaCorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Acknowledgments

The authors would like to thank all members of Zhejiang University Institute of Hematology for technical support to diagnosis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

RARγ-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen

Information for

Open access

Opportunities

Help and information

RARγ-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen

Acknowledgments

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature